Digital Content 
NEWS #PharmaBuzz
25 Mar 2025
// PRESS RELEASE
https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-25-06-00-00-3048411
12 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/13/2996609/0/en/Press-Release-Tolebrutinib-designated-Breakthrough-Therapy-by-the-FDA-for-non-relapsing-secondary-progressive-multiple-sclerosis.html
23 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/23/2951617/0/en/AB-Science-provides-an-update-on-the-development-of-masitinib-in-progressive-forms-of-multiple-sclerosis-post-ECTRIMS-2024.html
02 Sep 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-ms-drug-tolebrutinib-misses-goal-relapsing-disease-trials-2024-09-02/
28 Apr 2023
// Gabrielle Masson FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/fda-hold-isnt-slowing-sanofis-ms-plans-down-pharma-presents-new-safety-data
08 Aug 2022
// PRESS RELEASE
https://www.sanofi.com/en/media-room/press-releases/2022/2022-08-08-17-08-40-2494173
Share 